Genomics and transcriptomics of pancreatic adenosquamous carcinoma.

Authors

Brooke Kania

Brooke Elizabeth Kania

Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ

Brooke Elizabeth Kania , Yasmine Baca , Gregory Riedlinger , Sanjay Goel , Emil Lou , Benjamin Adam Weinberg , Moh'd M. Khushman , Joanne Xiu , Pat Gulhati

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 691)

DOI

10.1200/JCO.2024.42.3_suppl.691

Abstract #

691

Poster Bd #

M20

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

First Author: Karam Ashouri

Poster

2023 ASCO Annual Meeting

Molecular and clinical correlates of <em>DSCR1</em> expression in pancreatic cancer (PDAC).

Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).

First Author: Francesca Battaglin

Poster

2020 ASCO Virtual Scientific Program

Genomic mapping to identify mutations in RYR2 and AHNAK in basal-like breast tumors expressing PD-L1.

Genomic mapping to identify mutations in RYR2 and AHNAK in basal-like breast tumors expressing PD-L1.

First Author: Francisco J Cimas

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.

A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.

First Author: Jose Antonio Lopez Guerrero